Listar BCGF - Contribuciones a congresos científicos por autor "Visser, Rick"
Mostrando ítems 1-5 de 5
-
A synthetic collagen-binding arg-gly-asp (rgd) biomimetic peptide enhances bone cell differentiation
Visser, Rick
; Arrabal-García, Pilar María; Santos-Ruiz, Leonor; Fernández-Barranco, Raúl; Cifuentes-Rueda, Manuel; Becerra-Ratia, José[et al.] (2013-11-27)
RGD (arginine-glycine-aspartic acid) peptides have shown some promising abilities to promote the attachment of cells to biomaterials and to direct their differentiation. However, anchoring these peptides to the biomaterial’s ... -
Bioactive peptides. Formulations and indications
Visser, Rick (2022-09-26)
Comunicación "key-note" en el congreso de la Sociedad Europea de Regeneración Tisular en Ortopedia y Traumatología, en el que se sintetiza el diseño y empleo de péptidos biomiméticos en el ámbito de la ingeniería tisular ... -
Bone marrow mesenchymal stem cells, collagen scaffold and BMP-2 for rat spinal fusio
Arrabal-García, Pilar María; Visser, Rick; Cifuentes-Rueda, Manuel; Becerra-Ratia, José; Jiménez-Enjuto, E. (2013-11-08)
The use of autograft for posterolateral spinal fusion, continue being considered the gold standard for the treatment of spine pathologies. However, due to complications such as donor site morbidity, increased operating ... -
IGF-1 enhances the osteogenic activity of BMP-6 in vitro and in vivo
Rico-Llanos, Gustavo Adolfo; Becerra-Ratia, José; Visser, Rick (2017-10-25)
Bone morphogenetic protein-2 (BMP-2) is widely used in orthopedic surgery and bone tissue engineering because of its strong osteogenic activity. However, BMP-2 treatments have several drawbacks and alternatives are being ... -
IGF-1 enhances the osteogenic activity of BMP-6 in vitro and in vivo, and together have a stronger osteogenic effect than when IGF-1 is combined with BMP-2
Rico-Llanos, Gustavo Adolfo; Becerra-Ratia, José; Visser, Rick (2017-11-24)
Bone morphogenetic protein-2 (BMP-2) is widely used in orthopedic surgery and bone tissue engineering because of its strong osteogenic activity. However, BMP-2 treatments have several drawbacks and alternatives are being ...